Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Achievement and SLC22A1[original query] |
---|
A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia. British journal of haematology 2013 Dec 163 (5): 631-9. Grinfeld Jacob, Gerrard Gareth, Alikian Mary, Alonso-Dominguez Juan, Ale Sakuntala, Valgañon Mikel, Nteliopoulos Georgios, White Deborah, Marin David, Hedgley Corinne, O'Brien Stephen, Clark Richard, Goldman John M, Milojkovic Dragana, Apperley Jane F, Foroni Letiz |
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. Journal of clinical medicine 2022 10 11 (20): . Estrada Natalia, Zamora Lurdes, Ferrer-Marín Francisca, Palomo Laura, García Olga, Vélez Patricia, De la Fuente Iris, Sagüés Miguel, Cabezón Marta, Cortés Montserrat, Vallansot Rolando Omar, Senín-Magán María Alicia, Boqué Concepción, Xicoy Blan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: